Informa (INF) Receives Consensus Recommendation of “Buy” from Brokerages
Informa (LON:INF) has received a consensus recommendation of “Buy” from the fourteen analysts that are covering the company, MarketBeat reports. Six analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is GBX 801.44 ($10.75).
A number of research analysts recently issued reports on the company. Shore Capital reiterated a “hold” rating on shares of Informa in a research note on Wednesday, January 31st. Morgan Stanley reiterated an “equal weight” rating and set a GBX 770 ($10.33) price objective on shares of Informa in a research note on Wednesday, January 31st. Peel Hunt upgraded Informa to an “add” rating and set a GBX 740 ($9.93) price objective for the company in a research note on Friday, May 4th. Deutsche Bank reiterated a “buy” rating on shares of Informa in a research note on Wednesday, January 31st. Finally, Numis Securities reiterated an “add” rating and set a GBX 825 ($11.07) price objective on shares of Informa in a research note on Tuesday, January 30th.
Informa opened at GBX 782 ($10.49) on Monday, according to MarketBeat. Informa has a 52 week low of GBX 624.50 ($8.38) and a 52 week high of GBX 773 ($10.37).
Informa Company Profile
Informa plc engages in business intelligence, academic publishing, and knowledge and events businesses worldwide. The company operates through Academic Publishing, Business Intelligence, Global Exhibitions, and Knowledge & Networking segments. The Academic Publishing segment publishes academic books and journals in print and digital formats for university libraries and departments, specialist research institutions, and individuals in the areas of humanities and social sciences, science, technology, and medicine.
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.